Heparin as a therapy for COVID-19: current evidence and future possibilities
HEPARIN IN COVID-19

Abstract
Coronavirus disease 2019 (COVID-19), the clinical syndrome associated with infection by severe acute respiratory syndrome coronavirus 2 (